Literature DB >> 7914317

Urokinase receptor and colorectal cancer survival.

S Ganesh, C F Sier, M M Heerding, G Griffioen, C B Lamers, H W Verspaget.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7914317     DOI： 10.1016/s0140-6736(94)91427-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  37 in total

Review 1.  The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer.

Authors:  G Cox; W P Steward; K J O'Byrne
Journal:  Thorax       Date:  1999-02       Impact factor: 9.139

2.  Downregulation of uPAR confirms link in growth and metastasis of osteosarcoma.

Authors:  Crispin R Dass; Anne P W Nadesapillai; Daniel Robin; Monique L Howard; Jane L Fisher; Hong Zhou; Peter F M Choong
Journal:  Clin Exp Metastasis       Date:  2006-04-29       Impact factor: 5.150

3.  Posttranscriptional regulation of urokinase receptor gene expression in human lung carcinoma and mesothelioma cells in vitro.

Authors:  S Shetty; S Idell
Journal:  Mol Cell Biochem       Date:  1999-09       Impact factor: 3.396

Review 4.  Markers of tumor angiogenesis: clinical applications in prognosis and anti-angiogenic therapy.

Authors:  S B Fox; A L Harris
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

5.  Urokinase-type plasminogen activator receptor in gastric cancer: tissue expression and prognostic role.

Authors:  M Plebani; L Herszènyi; P Carraro; M De Paoli; G Roveroni; R Cardin; Z Tulassay; R Naccarato; F Farinati
Journal:  Clin Exp Metastasis       Date:  1997-07       Impact factor: 5.150

Review 6.  Is there a genetic signature for liver metastasis in colorectal cancer?

Authors:  Cristina Nadal; Joan Maurel; Pere Gascon
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

7.  Urokinase type plasminogen activator receptor expression in colorectal neoplasms.

Authors:  S Suzuki; Y Hayashi; Y Wang; T Nakamura; Y Morita; K Kawasaki; K Ohta; N Aoyama; S R Kim; H Itoh; Y Kuroda; W F Doe
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

8.  Tissue plasminogen activator induces pancreatic cancer cell proliferation by a non-catalytic mechanism that requires extracellular signal-regulated kinase 1/2 activation through epidermal growth factor receptor and annexin A2.

Authors:  Elena Ortiz-Zapater; Sandra Peiró; Oriol Roda; Josep M Corominas; Susana Aguilar; Coral Ampurdanés; Francisco X Real; Pilar Navarro
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

9.  Deoxycholic acid activates beta-catenin signaling pathway and increases colon cell cancer growth and invasiveness.

Authors:  Rama Pai; Andrzej S Tarnawski; Teresa Tran
Journal:  Mol Biol Cell       Date:  2004-03-05       Impact factor: 4.138

10.  Intact and cleaved forms of the urokinase receptor enhance discrimination of cancer from non-malignant conditions in patients presenting with symptoms related to colorectal cancer.

Authors:  A F Lomholt; G Høyer-Hansen; H J Nielsen; I J Christensen
Journal:  Br J Cancer       Date:  2009-08-11       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.